Bausch Health to Announce Second-Quarter 2023 Results on Aug. 3
LAVAL, QC / ACCESSWIRE / July 13, 2023 / Bausch Health Companies Inc. (NYSE/TSX:BHC) will release its second-quarter financial results...
Pharmaceutical
CureVac Strengthens Ongoing Patent Litigations Bringing Additional Cases Under New Intellectual Property Rights
Cases in Germany and the U.S. broadened by asserting additional, new intellectual property rightsThree new intellectual property rights added to...
Moderna to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023
CAMBRIDGE, MA / ACCESSWIRE / July 13, 2023 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics...
Scilex Holding Company Announces Results From Independent Market Research Study Conducted with Pain Specialists and HCPs Treating Post-Herpetic Neuralgia (PHN) Pain on ZTlido®
ZTlido® profile has been viewed as a leading prescription lidocaine patch by pain specialists. Based on the independent market research...
Lucy Scientific Discovery Inc. Taps Fortune 500 Veteran and Current Executive Chairman Richard Nanula as New CEO
Nanula former CFO at Amgen and The Walt Disney Corporation to Bring Significant Strategic Focus and Leadership to Lucy Scientific...
Skye Bioscience Receives Positive Safety Review for Final Cohort of Fully-Enrolled Phase 1 Study of SBI-100 Ophthalmic Emulsion
Skye preparing to start Phase 2a glaucoma clinical trial in Q3San Diego, California--(Newsfile Corp. - July 13, 2023) - Skye...
Parker Health Secures $25 Million in Series A Funding to Transform American Healthcare
WASHINGTON--(BUSINESS WIRE)--#parkerhealth--Parker Health an innovative biotech company for electronic health records, hospital developer & management, and subscription-based health services, today...
Medexus Announces Preliminary Revenue for Fiscal Q1 2024
Preliminary estimates indicate revenue is expected to exceed US$31 million for fiscal quarter ended June 30, 2023Toronto, Ontario and Chicago,...
Rexis Biotech Announces Strategic Partnership With 3CHI & Wefunder Crowdfunding Equity Raise
DOVER, DE / ACCESSWIRE / July 11, 2023 / Rexis Biotech Inc. ("REXIS") is delighted to announce its continued growth...
Glaukos to Release Second Quarter 2023 Financial Results after Market Close on August 2, 2023
Conference Call and Webcast Scheduled for 1:30 p.m. PTALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and...
Announcing Olink® Explore HT – A New Era in Proteomics
A High-throughput Protein Biomarker Discovery Platform with Proven Specificity at Any Scale Olink Explore HT Olink® Explore HT is a...
Sharps Technology Appoints Industry Sales and Manufacturing Leader Ben Scheu as Senior Director of Sales
Key appointment with demonstrated experience in leading sales and marketing operations to oversee commercial initiatives as the Company launches its...
Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery
Companies to collaborate on software for biotech and pharmaceutical companies to create improved patient treatments fasterSALT LAKE CITY, TORONTO and...
Apnimed to Participate in the William Blair Virtual Conference: Transitioning Biotech Breakthroughs to Commercial Success
CAMBRIDGE, Mass., July 12, 2023 (GLOBE NEWSWIRE) -- Apnimed, Inc., a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies...
Ultragenyx Appoints Howard Horn as Chief Financial Officer and Executive Vice President, Corporate Strategy
Howard Horn Ultragenyx announced Howard Horn has been appointed executive vice president and chief financial officer, effective October 16, 2023.NOVATO,...
LianBio Announces Clinical Supply Agreement with AstraZeneca in China to Evaluate BBP-398 in Combination with Osimertinib in Patients with Non-Small Cell Lung Cancer with EGFR Mutations
SHANGHAI, China and PRINCETON, N.J., July 12, 2023 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing...
Aridis’ AR-301 Monoclonal Antibody is Among the First Biologics to Receive FDA’s Qualified Infectious Diseases Product (QIDP) Designation
QIDP designation for Biologics provides FDA Priority Review statusLOS GATOS, Calif., July 12, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc....
Lumos Pharma to Participate in the Oppenheimer 2023 Montauk Life Sciences Summit
AUSTIN, Texas, July 12, 2023 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for...
Ocular Therapeutix™ Announces Appointment of New Board Member
Dr. Adrienne Graves to join Board of DirectorsBEDFORD, Mass., July 12, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL), a...
Slynd® (drospirenone) is now covered by the Régie de l’assurance maladie du Québec
Slynd® Slynd® is now reimbursed for 100% of Quebec women to whom it is indicated.BLAINVILLE, Quebec, July 12, 2023 (GLOBE...